Literature DB >> 2759925

Treatment of typhoid fever with ofloxacin.

F Wang1, X J Gu, M F Zhang, T Y Tai.   

Abstract

Ofloxacin, 300 mg 12-hourly, was given orally to 64 patients with typhoid fever, all with positive blood cultures. Almost 80% of the isolates were resistant to chloramphenicol, ampicillin and co-trimoxazole, but sensitive to ofloxacin and norfloxacin. Fever subsided within five days in most patients (mean 3.2 +/- 1.1), rates of clinical effectiveness and bacteriological cure both being 100%. Thirty patients were followed for 1-3 months after the completion of therapy with no occurrence of relapse.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2759925     DOI: 10.1093/jac/23.5.785

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  17 in total

1.  Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children.

Authors:  H Vinh; J Wain; T N Vo; N N Cao; T C Mai; D Bethell; T T Nguyen; S D Tu; M D Nguyen; N J White
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

3.  Outbreak of Multi-drug Resistant Salmonella Typhi Enteric Fever in Mumbai Garrison.

Authors:  R N Misra; K S Bawa; S K Magu; S Bhandari; A Nagendra; P K Menon
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  The concurrent prevalence of chloramphenicol-sensitive and multi-drug resistant Salmonella typhi in Vellore, S. India.

Authors:  M V Jesudason; R John; T J John
Journal:  Epidemiol Infect       Date:  1996-04       Impact factor: 2.451

Review 5.  Salmonella typhi and other salmonellas.

Authors:  B K Mandal
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

6.  DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A.

Authors:  Kenji Hirose; Ai Hashimoto; Kazumichi Tamura; Yoshiaki Kawamura; Takayuki Ezaki; Hiroko Sagara; Haruo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 7.  Quinolones in Salmonella typhi infection.

Authors:  H L DuPont
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients.

Authors:  L J Piddock; D J Griggs; M C Hall; Y F Jin
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

9.  Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial.

Authors:  A Islam; T Butler; I Kabir; N H Alam
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

10.  Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh.

Authors:  M Rahman; A K Siddique; S Shoma; H Rashid; M A Salam; Q S Ahmed; G B Nair; R F Breiman
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.